Ken Fisher’s ELITE PHARMACEUTICAL ELI Stock Holding History

Ken Fisher’s Portfolio ELI Stock Details ELI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-82,000	Closed	-$7.69K	–	1164
2023 Q3	$7.69K	Buy	+82,000	New	+$7.69K	﹤0.01%	1103
2023 Q2	–	Sell	-82,000	Closed	-$2.38K	–	1217
2023 Q1	$2.38K	Buy	+82,000	New	+$2.38K	﹤0.01%	1094
2022 Q4	–	Sell	-82,000	Closed	-$3K	–	1074
2022 Q3	$3K	Hold	82,000	–	–	﹤0.01%	931
2022 Q2	$4K	Hold	82,000	–	–	﹤0.01%	921
2022 Q1	$3K	Hold	82,000	–	–	﹤0.01%	944
2021 Q4	$3K	Buy	+82,000	New	+$3K	﹤0.01%	960

Ken Fisher's ELI Position: Q4 2023 in Review

Ken Fisher sold out of ELITE PHARMACEUTICAL (ELI) in Q4 2023, closing a stake of 82,000 shares — an estimated $7.69K sold.

Ken Fisher first reported a position in ELI in Q4 2021 and held it in 6 quarters. The position peaked at $7.69K in Q3 2023. 0 funds tracked by Wall St. Rank hold ELI as of Q4 2023.

Ken Fisher reported no remaining ELITE PHARMACEUTICAL position as of Q4 2023 after selling out during the quarter.
Ken Fisher sold 82,000 ELITE PHARMACEUTICAL shares in Q4 2023, an estimated $7.69K.
Ken Fisher first reported a position in ELITE PHARMACEUTICAL in Q4 2021 and held it in 6 quarters.
Ken Fisher's ELITE PHARMACEUTICAL position peaked at $7.69K in Q3 2023.
0 funds tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.